Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase 2 Open-Label Study of the Safety and Efficacy of Weekly Dosing of ATL1102 in Patients with Non-Ambulatory Duchenne Muscular Dystrophy and Pharmacology in Mdx Mice.

Ian R. Woodcock,George Tachas,Nuket Desem,Peter J. Houweling,Michael Kean,Jaiman Emmanuel,Rachel Kennedy,Kate Carroll,Katy de Valle,Justine Adams,Shireen R. Lamande,Chantal Coles,Chrystal Tiong,Matthew Burton,Daniella Villano, Peter Button,Jean-Yves Hogrel, Sarah Catling-Seyffer,Monique M. Ryan,Martin B. Delatycki,Eppie M. Yiu

PLOS ONE（2024）

Cited 4|Views16

Key words

Dystrophin

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined